111 related articles for article (PubMed ID: 31099823)
21. Aberrant expression of vimentin predisposes oral premalignant lesion derived cells towards transformation.
Dmello C; Sawant S; Chaudhari PR; Dongre H; Ahire C; D'Souza ZC; Charles SE; Rane P; Costea DE; Chaukar D; Kane S; Vaidya M
Exp Mol Pathol; 2018 Dec; 105(3):243-251. PubMed ID: 30189187
[TBL] [Abstract][Full Text] [Related]
22. [Clinical significance of the adenoma-carcinoma sequence. Results of a retrospective study].
Schlenkhoff D; Simon U; Strosche H
Zentralbl Chir; 1986; 111(18):1100-8. PubMed ID: 3788329
[TBL] [Abstract][Full Text] [Related]
23. Fas ligand upregulation is an early event in colonic carcinogenesis.
Bennett MW; O'Connell J; Houston A; Kelly J; O'Sullivan GC; Collins JK; Shanahan F
J Clin Pathol; 2001 Aug; 54(8):598-604. PubMed ID: 11477113
[TBL] [Abstract][Full Text] [Related]
24. The relationship between cyclooxygenase-2 expression and characteristics of malignant transformation in human colorectal adenomas.
Sheehan KM; O'Connell F; O'Grady A; Conroy RM; Leader MB; Byrne MF; Murray FE; Kay EW
Eur J Gastroenterol Hepatol; 2004 Jun; 16(6):619-25. PubMed ID: 15167166
[TBL] [Abstract][Full Text] [Related]
25. hMLH1, hMSH2 and cyclooxygenase-2 (cox-2) in sporadic colorectal polyps.
Balbinotti RA; Ribeiro U; Sakai P; Safatle-Ribeiro AV; Balbinotti SS; Scapulatempo C; Alves VA; Corbett CE; Carrilho FJ
Anticancer Res; 2007; 27(6C):4465-71. PubMed ID: 18214062
[TBL] [Abstract][Full Text] [Related]
26. Interplay between VHL/HIF1alpha and Wnt/beta-catenin pathways during colorectal tumorigenesis.
Giles RH; Lolkema MP; Snijckers CM; Belderbos M; van der Groep P; Mans DA; van Beest M; van Noort M; Goldschmeding R; van Diest PJ; Clevers H; Voest EE
Oncogene; 2006 May; 25(21):3065-70. PubMed ID: 16407833
[TBL] [Abstract][Full Text] [Related]
27. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
Engelhardt M; Drullinsky P; Guillem J; Moore MA
Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582
[TBL] [Abstract][Full Text] [Related]
28. Hyperplastic/serrated polyposis in inflammatory bowel disease: a case series of a previously undescribed entity.
Srivastava A; Redston M; Farraye FA; Yantiss RK; Odze RD
Am J Surg Pathol; 2008 Feb; 32(2):296-303. PubMed ID: 18223333
[TBL] [Abstract][Full Text] [Related]
29. Targeting TYRO3 inhibits epithelial-mesenchymal transition and increases drug sensitivity in colon cancer.
Chien CW; Hou PC; Wu HC; Chang YL; Lin SC; Lin SC; Lin BW; Lee JC; Chang YJ; Sun HS; Tsai SJ
Oncogene; 2016 Nov; 35(45):5872-5881. PubMed ID: 27132510
[TBL] [Abstract][Full Text] [Related]
30. The risk of metachronous neoplasia in patients with serrated adenoma.
Lazarus R; Junttila OE; Karttunen TJ; Mäkinen MJ
Am J Clin Pathol; 2005 Mar; 123(3):349-59. PubMed ID: 15716230
[TBL] [Abstract][Full Text] [Related]
31. Altered actin cytoskeletal patterns in two premalignant stages in human colon carcinoma development.
Friedman E; Verderame M; Lipkin M; Pollack R
Cancer Res; 1985 Jul; 45(7):3236-42. PubMed ID: 4039977
[TBL] [Abstract][Full Text] [Related]
32. Loss of expression of MLH1 in non-dysplastic crypts is a harbinger of neoplastic progression in sessile serrated adenomas/polyps.
Yozu M; Kem M; Cenaj O; Mino-Kenudson M; Odze RD; Misdraji J
Histopathology; 2019 Sep; 75(3):376-384. PubMed ID: 30974487
[TBL] [Abstract][Full Text] [Related]
33. MUC expression in hyperplastic and serrated colonic polyps: lack of specificity of MUC6.
Gibson JA; Hahn HP; Shahsafaei A; Odze RD
Am J Surg Pathol; 2011 May; 35(5):742-9. PubMed ID: 21490447
[TBL] [Abstract][Full Text] [Related]
34. Differential activation of total and EGF receptor (EGF-R) tyrosine kinase (tyr-k) in the rectal mucosa in patients with adenomatous polyps, ulcerative colitis and colon cancer.
Malecka-Panas E; Kordek R; Biernat W; Tureaud J; Liberski PP; Majumdar AP
Hepatogastroenterology; 1997; 44(14):435-40. PubMed ID: 9164515
[TBL] [Abstract][Full Text] [Related]
35. Pedunculated serrated polyp with histologic features of sessile serrated adenoma: a clinicopathologic and molecular study.
Kim MJ; Lee EJ; Chun SM; Jang SJ; Kim CH; Seo JP; Kim DS; Lee DH; Lee SH; Youk EG
Am J Surg Pathol; 2013 Jul; 37(7):1039-43. PubMed ID: 23648458
[TBL] [Abstract][Full Text] [Related]
36. Elevated c-yes tyrosine kinase activity in premalignant lesions of the colon.
Peña SV; Melhem MF; Meisler AI; Cartwright CA
Gastroenterology; 1995 Jan; 108(1):117-24. PubMed ID: 7806032
[TBL] [Abstract][Full Text] [Related]
37. Pathology of premalignant colorectal neoplasia.
Gibson JA; Odze RD
Dig Endosc; 2016 Apr; 28(3):312-23. PubMed ID: 26861656
[TBL] [Abstract][Full Text] [Related]
38. Paneth cell differentiation in colonic epithelial neoplasms: evidence for the role of the Apc/beta-catenin/Tcf pathway.
Joo M; Shahsafaei A; Odze RD
Hum Pathol; 2009 Jun; 40(6):872-80. PubMed ID: 19269007
[TBL] [Abstract][Full Text] [Related]
39. Ras oncogene p21 levels parallel malignant potential of different human colonic benign conditions.
Michelassi F; Leuthner S; Lubienski M; Bostwick D; Rodgers J; Handcock M; Block GE
Arch Surg; 1987 Dec; 122(12):1414-6. PubMed ID: 3318757
[TBL] [Abstract][Full Text] [Related]
40. Expression of Bcl-2 protein in hyperplastic polyps, adenomas, and carcinomas of the colon.
Flohil CC; Janssen PA; Bosman FT
J Pathol; 1996 Apr; 178(4):393-7. PubMed ID: 8691316
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
